Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination.
During 2009-2011, we reported that the oral and cervical prevalence of human papillomavirus (HPV) was high by international standards at 9.3% and 74%, respectively, in youth aged 15-23 years attending a youth clinic in Stockholm. After gradual introduction of public HPV vaccination during 2007-2012, between 2013 and 2014, when 73% of the women were HPV-vaccinated, but not necessarily before their sexual debut, oral HPV prevalence had dropped to 1.4% as compared with 9.3% in 2009-2011 (p < 0.00001). Cervical HPV prevalence was high and common cervical high-risk types were HPV51, 56, 59, 73, 16, 39, 52, and 53. However, it was shown that HPV16, 31, and 70 were significantly less common among HPV-vaccinated women than among those who had not received the vaccine.
From the Department of Oncology-Pathology, Karolinska Institutet , Stockholm , Sweden.
Nathalie
N
Grün
Andreas
A
Ährlund-Richter
Joar
J
Franzén
Leila
L
Mirzaie
Lena
L
Marions
Torbjörn
T
Ramqvist
Tina
T
Dalianis
D000293:Adolescent; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D032541:Mass Vaccination; D009059:Mouth Diseases / Q000453:epidemiology* / Q000517:prevention & control / Q000821:virology; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control; D015995:Prevalence; D013548:Sweden / Q000453:epidemiology; D002577:Uterine Cervical Diseases / Q000453:epidemiology* / Q000517:prevention & control / Q000821:virology; D055815:Young Adult
HPV; HPV in youth; HPV vaccination; cervical HPV infection; oral HPV infection